申请人:Hoechst Aktiengesellschaft
公开号:US04943576A1
公开(公告)日:1990-07-24
Substituted quinoxalyl-imidazolidine-2,4-diones, processes for their preparation, their use as medicaments and pharmaceutical preparations 5-Quinoxalyl-imidazolidine-2,4-diones of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 have the meanings given, and physiologically tolerated salts thereof and processes for their preparation are described. The compounds inhibit aldose reductase and can be used as medicaments.
取代的喹喹啉基咪唑啉-2,4-二酮,其制备方法,作为药物和药物制剂使用的过程。公式I的5-喹啉基咪唑啉-2,4-二酮
其中R.sup.1、R.sup.2、R.sup.3、R.sup.4和R.sup.5具有给定的含义,以及其生理耐受盐和其制备方法。这些化合物抑制醛糖还原酶,可用作药物。